Big Pharma rescues flailing 'cancer vaccine' company with $300 million buyout

The deal comes four months after Immune Design Corp. halted its lead cancer vaccine trial and restructured its drug development plans.

Source: bizjournals.com Health Care:Biotechnology headlines - February 21, 2019 Category: Biotechnology Authors: Casey Coombs Source Type: news